Skip to content
OpenCapital
Get started

Agilon Health AGL Proceeds From Sale And Maturity Of Available For Sale Securities

Proceeds From Sale And Maturity Of Available For Sale Securities at other companies

Automatic Data Processing, Inc. logo
Automatic Data Processing, Inc.ADP
$2.93B+133%
General Motors logo
General MotorsGM
$2.85B+167%
Edwards Lifesciences logo
Edwards LifesciencesEW
$710.1M-14.2%
ServiceNow logo
ServiceNowNOW
$1.14B-3.6%
Equitable Holdings logo
Equitable HoldingsEQH
$2.76B-38.2%
Atlantic Union Bankshares logo
Atlantic Union BanksharesAUB
$80.14M+93.7%

Other financials

Income statement

See full
Revenue$1.4B-7.3%
Operating income$4.0M+118%
Net income$48.9M+304%
EPS (diluted)$2.94+303%

Balance sheet

See full
Cash & equivalents$211.6M+52.6%
Total debt$33.4M-20.5%
Total equity$181.4M-63.7%
Total assets$1.5B-22.1%

Cash flow

See full
Operating cash flow$23.7M+174%
CapEx$3.1M-19.4%
Free cash flow$20.6M+158%

Valuation

See full
Market cap$1.78B-92.6%
Enterprise value$1.61B-103%
P/S0.3×-3.8×

Profitability

See full
Operating margin-7.5%+6.5pp
Net margin-6.1%+6.3pp
FCF margin-1.1%—

Returns & leverage

See full
Return on equity-104%-291pp
Debt / equity0.2×+0.1×
Current ratio1×-0.2×

Where this comes from

Reported directly by Agilon Health in its filing.

Tagged under the XBRL concept us-gaap:ProceedsFromSaleAndMaturityOfAvailableForSaleSecurities.

The official record: Agilon Health’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Agilon Health's proceeds from sale and maturity of available for sale securities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Agilon Health's proceeds from sale and maturity of available for sale securities?
Agilon Health (AGL) reported proceeds from sale and maturity of available for sale securities of $22.4M in Q1 2026.
How has Agilon Health's proceeds from sale and maturity of available for sale securities changed year-over-year?
Agilon Health's proceeds from sale and maturity of available for sale securities decreased by 36.6% year-over-year, from $35.31M to $22.4M.
What is the long-term trend for Agilon Health's proceeds from sale and maturity of available for sale securities?
Over 2 years (2021 to 2024), Agilon Health's proceeds from sale and maturity of available for sale securities has grown at a 440.0% compound annual growth rate (CAGR), from $7.1M to $206.92M.